This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Kick off an IRA with zero-commission index funds, focusing on cost-effective options and straightforward fund selection.
17,767 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Morgan Stanley warns a disruption through the Strait of Hormuz could lift Brent to as high as $150 a barrel by summer...
Abe Foxman, the longtime director of the Anti-Defamation League, has died at age 86. His 28-year tenure shaped anti-h...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
New on-chain data shows a growing cohort of XRP whales, with wallets holding 10,000 XRP or more rising to a new high....
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
A late-breaking disclosure shows substantial purchases in Boeing and Nvidia by Donald Trump, as markets brace for a h...
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
JPMorgan raised its price target on Dell Technologies to 280 amid easing memory headwinds and a robust AI server back...
Portfolio manager Ben Carlson argues that avoiding big-ticket upgrades can shield households and portfolios from infl...
A prominent fund has poured roughly $55 million into Dianthus as the stock climbs 350%. This article breaks down what...
A prominent investment advisor just made a sizable play in a well-known theme park company. This article dives into t...